Nuvectis Pharma to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Fort Lee, NJ, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage...
Clinical Trial
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Voyager to receive upfront consideration of $15 million and is eligible to receive up to $305 million in potential associated...
Palisade Bio Reports Data Demonstrating PDE4B Expression in Patient Cohorts Could be Utilized as a Potential Marker for Patient Stratification
Curated data show expression of PDE4B above a specific measurable threshold observed in 70% of adult colitis patients and 90%...
4DMT Announces Presentations at Upcoming Retina Conferences
EMERYVILLE, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage...
Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia
Top-line data from VEGA-3 Phase 3 trial expected in first half of 2025 Top-line data from LYNX-2 Phase 3 trial...
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration
NANJING, China, Sept. 5, 2024 /PRNewswire/ -- On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets...
Expert Speaker Line-Up Revealed for Industry-Leading RBQM Event
CluePoints Supports Launch of RBQMLive 2024 as Premier Event Sponsor KING OF PRUSSIA, Pa., Sept. 4, 2024 /PRNewswire/ -- CluePoints,...
Signant Health expands availability of its eClinical solutions by joining IQVIA One Home for Sites initiative
PHILADELPHIA, Sept. 4, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced today it...
Clouds of Care Secures 5 Million Euros to Propel CNS Healthcare Innovation and appoints former CEO of Biogen, Michel Vounatsos, as chairman of the board of directors
GHENT, Belgium, Sept. 4, 2024 /PRNewswire/ -- Clouds of Care, a leading MedTech company dedicated to enabling better care for people with...
Phesi Receives Frost & Sullivan’s Global Enabling Technology Leadership Award for Revolutionizing Clinical Development with Its Trial Accelerator Platform
Phesi's Trial Accelerator™ Platform empowers trial sponsors to make informed decisions swiftly, expediting drug development timelines while upholding the highest...
HealthVerity introduces taXOnomy℠, the nation’s most comprehensive closed (X) and open (O) claims dataset for pharmaceutical research
PHILADELPHIA, Sept. 4, 2024 /PRNewswire/ -- HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the...
Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials network
Emmes, part of Emmes Group, today announced they will provide a Clinical Coordinating Center for the NIH's National Institute on...
EmVenio Research joins SCRS as Global Impact Partner
Research organization has been active SCRS member since 2022 founding DURHAM, N.C., Sept. 4, 2024 /PRNewswire/ -- Clinical research organization...
Lindus Health Launches “All-in-One Ophthalmology CRO” Tailored to Clinical Trials in Ophthalmology
NEW YORK, Sept. 4, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life...
Waterdrop Inc. Announces Second Quarter 2024 Unaudited Financial Results and a Special Cash Dividend
BEIJING, Sept. 4, 2024 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated...
Stemtech Corporation Announces Uplist to OTCQB, Maintains Focus on Expansion and Transparency
NAPLES, FL / ACCESSWIRE / September 4, 2024 / ("STEK") Stemtech Corporation, the pioneer and trailblazer in the stem cell...
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications
MIAMI, FL / ACCESSWIRE / September 4, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a pre-clinical-stage company...
Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
ORLANDO, FL / ACCESSWIRE / September 4, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has reported its financial results for the second...
Therma Bright Congratulates John Patton, PhD of InStatin on Receiving the Prestigious Charles G. Thiel Award
Chairman of Therma Bright's Strategic Investment Partner Recognized for Outstanding Research and Discovery in Respiratory Drug DeliveryToronto, Ontario--(Newsfile Corp. -...
NovaSight Announces Publication of Study Showing CureSight’s Superiority Over Patching
Patients Using the CureSight Digital Eye-Tracking Device for Amblyopia Treatment Achieved Significantly Greater Visual Acuity Gains in Per-Protocol AnalysisAIRPORT CITY,...